BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Ozaki I, Mizuta T, Matsuhashi S, Yoshimura T, Hisatomi A, Tadano J, Sakai T, Yamamoto K. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway. Cancer. 2002;95:896-906. [PMID: 12209735 DOI: 10.1002/cncr.10751] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Cai Q, Lanting L, Natarajan R. Interaction of monocytes with vascular smooth muscle cells regulates monocyte survival and differentiation through distinct pathways. Arterioscler Thromb Vasc Biol 2004;24:2263-70. [PMID: 15458980 DOI: 10.1161/01.ATV.0000146552.16943.5e] [Cited by in Crossref: 47] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
2 Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene. 2006;25:3866-3884. [PMID: 16799628 DOI: 10.1038/sj.onc.1209550] [Cited by in Crossref: 269] [Cited by in F6Publishing: 260] [Article Influence: 16.8] [Reference Citation Analysis]
3 Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 2004;28:38-44. [PMID: 14707728 DOI: 10.1097/00006676-200401000-00006] [Cited by in Crossref: 165] [Cited by in F6Publishing: 192] [Article Influence: 9.2] [Reference Citation Analysis]
4 Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat 2012;15:39-49. [PMID: 22335920 DOI: 10.1016/j.drup.2012.01.006] [Cited by in Crossref: 261] [Cited by in F6Publishing: 252] [Article Influence: 26.1] [Reference Citation Analysis]
5 Hebbar M, Ernst O, Cattan S, Dominguez S, Oprea C, Mathurin P, Triboulet J, Paris J, Pruvot F. Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma. Oncology 2006;70:154-8. [DOI: 10.1159/000093007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
6 L Addison C. Modulation of response to tumor therapies by the extracellular matrix. Future Oncology 2006;2:417-29. [DOI: 10.2217/14796694.2.3.417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
7 Faltas BM, Prandi D, Tagawa ST, Molina AM, Nanus DM, Sternberg C, Rosenberg J, Mosquera JM, Robinson B, Elemento O, Sboner A, Beltran H, Demichelis F, Rubin MA. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nat Genet 2016;48:1490-9. [PMID: 27749842 DOI: 10.1038/ng.3692] [Cited by in Crossref: 139] [Cited by in F6Publishing: 141] [Article Influence: 23.2] [Reference Citation Analysis]
8 Santos SN, Junqueira MS, Francisco G, Vilanova M, Magalhães A, Dias Baruffi M, Chammas R, Harris AL, Reis CA, Bernardes ES. O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. Oncotarget 2016;7:83570-87. [PMID: 27835877 DOI: 10.18632/oncotarget.13192] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
9 Molina MF, Abdelnabi MN, Fabre T, Shoukry NH. Type 3 cytokines in liver fibrosis and liver cancer. Cytokine 2019;124:154497. [DOI: 10.1016/j.cyto.2018.07.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Andjilani M, Droz JP, Benahmed M, Tabone E. Alpha6 integrin subunit mediates laminin enhancement of cisplatin-induced apoptosis in testicular tumor germ cells. Int J Cancer 2005;117:68-81. [PMID: 15880592 DOI: 10.1002/ijc.21144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
11 Dittmer J, Leyh B. The impact of tumor stroma on drug response in breast cancer. Semin Cancer Biol. 2015;31:3-15. [PMID: 24912116 DOI: 10.1016/j.semcancer.2014.05.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
12 Zhou F, Huang X, Zhang Z, Chen Y, Liu X, Xing J, He X. Functional polymorphisms of ITGB1 are associated with clinical outcome of Chinese patients with resected colorectal cancer. Cancer Chemother Pharmacol 2015;75:1207-15. [PMID: 25894721 DOI: 10.1007/s00280-015-2745-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
13 Cordes N. Integrin-mediated cell–matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury. Cancer Letters 2006;242:11-9. [DOI: 10.1016/j.canlet.2005.12.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
14 Takeda I, Maruya S, Shirasaki T, Mizukami H, Takahata T, Myers JN, Kakehata S, Yagihashi S, Shinkawa H. Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007;98:890-899. [PMID: 17428261 DOI: 10.1111/j.1349-7006.2007.00471.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
15 Sun C, Qu X, Gao Z. Integrins: players in cancer progression and targets in cancer therapy. Anti-Cancer Drugs 2014;25:1107-21. [DOI: 10.1097/cad.0000000000000145] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
16 Kim MY, Cho WD, Hong KP, Choi da B, Hong JW, Kim S, Moon YR, Son SM, Lee OJ, Lee HC, Song HG. Novel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cells. J Biomed Res 2016;30:217-24. [PMID: 27533932 DOI: 10.7555/JBR.30.2016K0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wu XZ, Chen D, Xie GR. Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed? Med Hypotheses 2006;66:1115-20. [PMID: 16504415 DOI: 10.1016/j.mehy.2005.12.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
18 Cao L, Wu Y, Wang X, Li X, Tan Z, Guan F. Role of Site-Specific Glycosylation in the I-Like Domain of Integrin β1 in Small Extracellular Vesicle-Mediated Malignant Behavior and FAK Activation. Int J Mol Sci 2021;22:1770. [PMID: 33578954 DOI: 10.3390/ijms22041770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jinturkar KA, Anish C, Kumar MK, Bagchi T, Panda AK, Misra AR. Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials 2012;33:2492-507. [PMID: 22200537 DOI: 10.1016/j.biomaterials.2011.11.067] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
20 Wu P, Gao W, Su M, Nice EC, Zhang W, Lin J, Xie N. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Front Cell Dev Biol 2021;9:641469. [PMID: 33732706 DOI: 10.3389/fcell.2021.641469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
21 Cordes N, Park CC. beta 1 integrin as a molecular therapeutic target. International Journal of Radiation Biology 2009;83:753-60. [DOI: 10.1080/09553000701639694] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
22 Fang H, Tong W, Perkins R, Shi L, Hong H, Cao X, Xie Q, Yim SH, Ward JM, Pitot HC. Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. BMC Bioinformatics. 2005;6 Suppl 2:S6. [PMID: 16026603 DOI: 10.1186/1471-2105-6-S2-S6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
23 Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65-75. [PMID: 25117005 DOI: 10.1016/j.semcancer.2014.07.009] [Cited by in Crossref: 127] [Cited by in F6Publishing: 135] [Article Influence: 15.9] [Reference Citation Analysis]
24 Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 2012;56:769-75. [PMID: 22378017 DOI: 10.1002/hep.25670] [Cited by in Crossref: 272] [Cited by in F6Publishing: 257] [Article Influence: 27.2] [Reference Citation Analysis]
25 Ma WL, Jeng LB, Lai HC, Liao PY, Chang C. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells. Cancer Lett 2014;351:64-71. [PMID: 24944078 DOI: 10.1016/j.canlet.2014.05.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
26 Semela D, Dufour JF. Angiogenesis and hepatocellular carcinoma. J Hepatol. 2004;41:864-880. [PMID: 15519663 DOI: 10.1016/j.jhep.2004.09.006] [Cited by in Crossref: 250] [Cited by in F6Publishing: 236] [Article Influence: 14.7] [Reference Citation Analysis]
27 Lee SK, Kim MH, Cheong JY, Cho SW, Yang SJ, Kwack K. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma. Liver Int 2009;29:187-95. [PMID: 18694400 DOI: 10.1111/j.1478-3231.2008.01843.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
28 Seviour EG, Sehgal V, Lu Y, Luo Z, Moss T, Zhang F, Hill SM, Liu W, Maiti SN, Cooper L, Azencot R, Lopez-Berestein G, Rodriguez-Aguayo C, Roopaimoole R, Pecot CV, Sood AK, Mukherjee S, Gray JW, Mills GB, Ram PT. Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. Oncogene 2016;35:691-701. [PMID: 25639871 DOI: 10.1038/onc.2014.469] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
29 Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, Yamamoto K. Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells. Cancer Sci. 2004;95:878-886. [PMID: 15546505 DOI: 10.1111/j.1349-7006.2004.tb02197.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
30 Qiu JW, Guo W, Shen LJ. Advances in research on p38MAPK-related hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(5): 503-509 [DOI: 10.11569/wcjd.v16.i5.503] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Ozaki I, Hamajima H, Matsuhashi S, Mizuta T. Regulation of TGF-β1-induced pro-apoptotic signaling by growth factor receptors and extracellular matrix receptor integrins in the liver. Front Physiol. 2011;2:78. [PMID: 22028694 DOI: 10.3389/fphys.2011.00078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
32 Jo J, de Mejia EG, Lila MA. Cytotoxicity of bioactive polymeric fractions from grape cell culture on human hepatocellular carcinoma, murine leukemia and non-cancerous PK15 kidney cells. Food and Chemical Toxicology 2006;44:1758-67. [DOI: 10.1016/j.fct.2006.05.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
33 Schuppan D, Ocker M. Integrin-mediated control of cell growth. Hepatology 2003;38:289-91. [PMID: 12883471 DOI: 10.1053/jhep.2003.50338] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
34 Lee YA, Friedman SL. Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C? Antiviral Res 2014;107:23-30. [PMID: 24726738 DOI: 10.1016/j.antiviral.2014.03.012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 10.3] [Reference Citation Analysis]
35 Hess F, Estrugo D, Fischer A, Belka C, Cordes N. Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells. Oncogene 2007;26:1372-84. [PMID: 16936772 DOI: 10.1038/sj.onc.1209947] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
36 Dey S, Liu S, Factora TD, Taleb S, Riverahernandez P, Udari L, Zhong X, Wan J, Kota J. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment. BMC Cancer 2020;20:651. [PMID: 32660466 DOI: 10.1186/s12885-020-07135-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Zhang CY, Hu P, Fu D, Wu W, Jia CY, Zhu XC, Wu XZ. 3'-Sulfo-Le(x) is important for regulation of integrin subunit alphaV. Biochemistry 2010;49:7811-20. [PMID: 20695481 DOI: 10.1021/bi101040k] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
38 Caccia D, Miccichè F, Cassinelli G, Mondellini P, Casalini P, Bongarzone I. Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line. Mol Cancer 2010;9:278. [PMID: 20955590 DOI: 10.1186/1476-4598-9-278] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
39 Ng L, Tung-ping Poon R, Yau S, Chow A, Lam C, Li H, Chung-cheung Yau T, Law W, Pang R. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion: Hepatology. Hepatology 2013;58:667-79. [DOI: 10.1002/hep.26396] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
40 Petrov RA, Mefedova SR, Yamansarov EY, Maklakova SY, Grishin DA, Lopatukhina EV, Burenina OY, Lopukhov AV, Kovalev SV, Timchenko YV, Ondar EE, Ivanenkov YA, Evteev SA, Vaneev AN, Timoshenko RV, Klyachko NL, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma. Mol Pharm 2021;18:461-8. [PMID: 33264010 DOI: 10.1021/acs.molpharmaceut.0c00980] [Reference Citation Analysis]
41 Bechmann N, Ehrlich H, Eisenhofer G, Ehrlich A, Meschke S, Ziegler CG, Bornstein SR. Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro. Mar Drugs 2018;16:E172. [PMID: 29783778 DOI: 10.3390/md16050172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
42 Zhang Y, Fan XG, Chen R, Xiao ZQ, Feng XP, Tian XF, Chen ZH. Comparative proteome analysis of untreated and Helicobacter pylori-treated HepG2. World J Gastroenterol 2005; 11(22): 3485-3489 [PMID: 15948260 DOI: 10.3748/wjg.v11.i22.3485] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
43 Lovitt CJ, Shelper TB, Avery VM. Advanced cell culture techniques for cancer drug discovery. Biology (Basel). 2014;3:345-367. [PMID: 24887773 DOI: 10.3390/biology3020345] [Cited by in Crossref: 120] [Cited by in F6Publishing: 125] [Article Influence: 15.0] [Reference Citation Analysis]
44 Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Hisatomi A, Tadano J, Sakai T, Yamamoto K. Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2. Hepatology 2003;38:305-13. [PMID: 12883474 DOI: 10.1053/jhep.2003.50345] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
45 Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta. 2007;1775:163-180. [PMID: 17084981 DOI: 10.1016/j.bbcan.2006.09.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 154] [Article Influence: 3.5] [Reference Citation Analysis]
46 Bai X, Wang J, Guo Y, Pan J, Yang Q, Zhang M, Li H, Zhang L, Ma J, Shi F. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway. Sci Rep. 2014;4:6538. [PMID: 25289898 DOI: 10.1038/srep06538] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
47 Karacaer NT, Kerimoğlu B, Baran T, Tarhan M, Menteş A, Öztürk K. Antitumor and apoptotic effects of new-generation platinum compounds on human leukemia cell lines HL-60 and K562. Biologia 2022;77:249-60. [DOI: 10.1007/s11756-021-00930-7] [Reference Citation Analysis]
48 He R, Leeson A, Ballantine M, Andonov A, Baker L, Dobie F, Li Y, Bastien N, Feldmann H, Strocher U, Theriault S, Cutts T, Cao J, Booth TF, Plummer FA, Tyler S, Li X. Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus. Virus Res 2004;105:121-5. [PMID: 15351485 DOI: 10.1016/j.virusres.2004.05.002] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 4.6] [Reference Citation Analysis]
49 Tao Y, Wei Q, Xu Z, Bai R, Li Y, Luo C, Dong Y, Gao G, Lu Y. Holistic and network analysis of meningioma pathogenesis and malignancy. BioFactors 2006;28:203-19. [DOI: 10.1002/biof.5520280307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]